$320.88
2.96% yesterday
NYSE, Nov 21, 10:10 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$320.88
+33.63 11.71% 1M
-16.13 4.79% 6M
-31.24 8.87% YTD
-31.61 8.97% 1Y
-116.80 26.69% 3Y
+173.53 117.77% 5Y
+269.99 530.54% 10Y
NYSE, Closing price Thu, Nov 21 2024
+9.22 2.96%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $22.57b
Enterprise Value $22.39b
P/E (TTM) P/E ratio 46.23
EV/FCF (TTM) EV/FCF 69.61
EV/Sales (TTM) EV/Sales 7.78
P/S ratio (TTM) P/S ratio 7.85
P/B ratio (TTM) P/B ratio 8.21
Dividend yield 0.25%
Last dividend (FY23) $0.78
Revenue growth (TTM) Revenue growth -1.70%
Revenue (TTM) Revenue $2.88b
EBIT (operating result TTM) EBIT $596.20m
Free Cash Flow (TTM) Free Cash Flow $321.60m
Cash position $490.90m
EPS (TTM) EPS $6.74
P/E forward 47.21
P/S forward 7.83
EV/Sales forward 7.76
Short interest 2.59%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
50%
Hold
50%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,876 2,876
2% 2%
100%
- Direct Costs 1,870 1,870
3% 3%
65%
1,007 1,007
10% 10%
35%
- Selling and Administrative Expenses 191 191
9% 9%
7%
- Research and Development Expense 69 69
5% 5%
2%
747 747
11% 11%
26%
- Depreciation and Amortization 151 151
14% 14%
5%
EBIT (Operating Income) EBIT 596 596
16% 16%
21%
Net Profit 500 500
11% 11%
17%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Positive
Seeking Alpha
15 days ago
This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks. The list is created using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ,...
Neutral
PRNewsWire
24 days ago
EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024 at 3:30 PM PST Jefferies Healthcare Conference in London, UK on Tuesday...
Neutral
Seeking Alpha
28 days ago
West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Lawrence Solow - CJS Secu...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today